Browsing by Author Huh, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 4 of 4 < previous 
TitleAuthor(s)Issue DateViews
 
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
Journal:Blood
Xu-Monette, ZYWu, LVisco, CTai, YCTzankov, ALiu, WMMontes-Moreno, SDybkaer, KChiu, AOrazi, AZu, YBhagat, GRichards, KLHsi, EDZhao, XFChoi, WLZhao, Xvan Krieken, JHHuang, QHuh, JAi, WPonzoni, MFerreri, AJZhou, FKahl, BSWinter, JNXu, WLi, JGo, RSLi, YPiris, MAMoller, MBMiranda, RNAbruzzo, LVMedeiros, LJYoung, KH
2012
121
 
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Journal:Blood
Hu, SXu-Monette, ZYTzankov, AGreen, TWu, LBalasubramanyam, ALiu, WMVisco, CLi, YMiranda, RNMontes-Moreno, SDybkaer, KChiu, AOrazi, AZu, YBhagat, GRichards, KLHsi, EDChoi, WWLZhao, Xvan Krieken, JHHuang, QHuh, JAi, WPonzoni, MFerreri, AJMZhou, FSlack, GWGascoyne, RDTu, MVariakojis, DChen, WGo, RSPiris, MAMøller, MBMedeiros, LJYoung, KH
2013
46
 
Prognostic significance and phenotypic manifestations of MYC/BCL2 protein expression in diffuse large B-cell lymphoma (DLBCL) with extranodal organ involvement: a report of the International DLBCL Rituximab-CHOP Consortium Program Study
Proceeding/Conference:Blood
Madadi, ARaghavendra, MHu, SXu-Monette, ZYVisco, CTzankov, AMontes-Moreno, SDybkaer, KChiu, AOrazi, AZu, YBhagat, GDunphy, CHHsi, EDZhao, FXChoi, WWLZhao, XVan Krieken, JHJMHuh, JHuang, QAi, WPonzoni, MFerreri, AJMZhou, FWinter, JNPiris, MMøller, MBMedeiros, LJGo, RSYoung, KH
2012
57
Showing results 2 to 4 of 4 < previous